Cargando…
Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study
OBJECTIVE: To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carcinoma (mRCC). METHODS: A total of 177 mRCC patients using sorafenib as first- (N = 116), second- (N = 43), and third-line (N = 18) therapies were enrolled from 11 Korean centers between 200...
Autores principales: | Kim, Sung Han, Kim, Sohee, Nam, Byung-Ho, Lee, Sang Eun, Kim, Choung Soo, Seo, Ill Young, Kim, Tae Nam, Hong, Sung-Hoo, Kwon, Tae Gyun, Seo, Seong Il, Joo, Kwan Joong, Song, Kanghyon, Kwak, Cheol, Chung, Jinsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550402/ https://www.ncbi.nlm.nih.gov/pubmed/26308612 http://dx.doi.org/10.1371/journal.pone.0135165 |
Ejemplares similares
-
Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study
por: Kim, Sung Han, et al.
Publicado: (2017) -
Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2016) -
Trends in clinical, operative, and pathologic characteristics of surgically treated renal mass in a Korean center: A surgical series from 1988 through 2015
por: Kang, Ho Won, et al.
Publicado: (2019) -
Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
por: Park, Jae Young, et al.
Publicado: (2020) -
Lifestyle Risk Prediction Model for Prostate Cancer in a Korean Population
por: Kim, Sung Han, et al.
Publicado: (2018)